Cardlytics
CDLX
110 hedge funds and large institutions have $173M invested in Cardlytics in 2023 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 34 increasing their positions, 32 reducing their positions, and 11 closing their positions.
77% more capital invested
Capital invested by funds: $97.9M → $173M (+$75.5M)
64% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 11
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
7% more funds holding
Funds holding: 103 → 110 (+7)
6% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 32
0.48% less ownership
Funds ownership: 8.56% → 8.08% (-0.48%)
67% less call options, than puts
Call options by funds: $722K | Put options by funds: $2.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$1.63M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$1.57M |
| 3 |
6CM
683 Capital Management
New York
|
+$1.36M |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$1.35M |
| 5 |
BCP
Berylson Capital Partners
Boston,
Massachusetts
|
+$897K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GEH
General Equity Holdings
Brooklyn,
New York
|
-$6.07M |
| 2 |
Two Sigma Investments
New York
|
-$3.28M |
| 3 |
Two Sigma Advisers
New York
|
-$2.56M |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.48M |
| 5 |
Walleye Capital
New York
|
-$1.2M |
CDLX Hedge Fund Activity: Q2 2023 in Review
110 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q2 2023, worth a combined $173M — up 77% from $97.9M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new CDLX positions and 11 closed out — a net gain of 7 holders — while 34 added to existing stakes and 32 trimmed.
The largest buyer was BlackRock, adding an estimated $1.63M. The largest seller was General Equity Holdings, cutting an estimated $6.07M.
- 110 institutional investors held Cardlytics (CDLX) as of Q2 2023, up from 103 in Q1 2023.
- Funds reported $173M of Cardlytics stock for Q2 2023, up 77% quarter-over-quarter.
- 18 funds opened new Cardlytics positions in Q2 2023 and 11 closed out, a net change of +7 holders.
- The largest Cardlytics buyer in Q2 2023 was BlackRock, an estimated $1.63M added.
- The largest Cardlytics seller in Q2 2023 was General Equity Holdings, an estimated $6.07M sold.
Based on aggregated 13F filings for Q2 2023.